Atlas Trials

Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL

Clinical trial NCT02848911 · TERMINATED

Trial details

NCT number
NCT02848911
Sponsor
Affimed GmbH
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Leukemia, B-Cell
Start date
2016-10-01
Primary completion
2018-09-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.